These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 17269937)

  • 21. Targeting factor VIII expression to platelets for hemophilia A gene therapy does not induce an apparent thrombotic risk in mice.
    Baumgartner CK; Mattson JG; Weiler H; Shi Q; Montgomery RR
    J Thromb Haemost; 2017 Jan; 15(1):98-109. PubMed ID: 27496751
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelet-targeted gene therapy with human factor VIII establishes haemostasis in dogs with haemophilia A.
    Du LM; Nurden P; Nurden AT; Nichols TC; Bellinger DA; Jensen ES; Haberichter SL; Merricks E; Raymer RA; Fang J; Koukouritaki SB; Jacobi PM; Hawkins TB; Cornetta K; Shi Q; Wilcox DA
    Nat Commun; 2013; 4():2773. PubMed ID: 24253479
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Altered bioavailability of platelet-derived factor VIII during thrombocytosis reverses phenotypic efficacy in haemophilic mice.
    Damon AL; Scudder LE; Gnatenko DV; Sitaraman V; Hearing P; Jesty J; Bahou WF
    Thromb Haemost; 2008 Dec; 100(6):1111-22. PubMed ID: 19132238
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correction of murine hemophilia A by hematopoietic stem cell gene therapy.
    Moayeri M; Hawley TS; Hawley RG
    Mol Ther; 2005 Dec; 12(6):1034-42. PubMed ID: 16226058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apoptotic effects of platelet factor VIII on megakaryopoiesis: implications for a modified human FVIII for platelet-based gene therapy.
    Greene TK; Lyde RB; Bailey SC; Lambert MP; Zhai L; Sabatino DE; Camire RM; Arruda VR; Poncz M
    J Thromb Haemost; 2014 Dec; 12(12):2102-12. PubMed ID: 25287191
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characteristics of the Thrombus Formation in Transgenic Mice with Platelet-Targeted Factor VIII Expression.
    Wang Y; Mao J; Li L; Xiao B; Ruan Z; Liu Y; Zhang G; Wang D; Mi JQ; Fang C; Xi X; Shi X; Wang J
    Thromb Haemost; 2022 May; 122(5):755-766. PubMed ID: 34587639
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FVIII expression by its native promoter sustains long-term correction avoiding immune response in hemophilic mice.
    Merlin S; Famà R; Borroni E; Zanolini D; Bruscaggin V; Zucchelli S; Follenzi A
    Blood Adv; 2019 Mar; 3(5):825-838. PubMed ID: 30862611
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factor IX ectopically expressed in platelets can be stored in alpha-granules and corrects the phenotype of hemophilia B mice.
    Zhang G; Shi Q; Fahs SA; Kuether EL; Walsh CE; Montgomery RR
    Blood; 2010 Aug; 116(8):1235-43. PubMed ID: 20445020
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The severe spontaneous bleeding phenotype in a novel hemophilia A rat model is rescued by platelet FVIII expression.
    Shi Q; Mattson JG; Fahs SA; Geurts AM; Weiler H; Montgomery RR
    Blood Adv; 2020 Jan; 4(1):55-65. PubMed ID: 31899798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ectopic Expression of FVIII in HPCs and MSCs Derived from hiPSCs with Site-Specific Integration of
    Zhao J; Zhou M; Wang Z; Wu L; Hu Z; Liang D
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet-delivered factor VIII provides limited resistance to anti-factor VIII inhibitors.
    Gewirtz J; Thornton MA; Rauova L; Poncz M
    J Thromb Haemost; 2008 Jul; 6(7):1160-6. PubMed ID: 18433455
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhancing therapeutic efficacy of in vivo platelet-targeted gene therapy in hemophilia A mice.
    Wang X; Fu RY; Li C; Chen CY; Firrman J; Konkle BA; Zhang J; Li L; Xiao W; Poncz M; Miao CH
    Blood Adv; 2020 Nov; 4(22):5722-5734. PubMed ID: 33216891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hematopoietic stem cells encoding porcine factor VIII induce pro-coagulant activity in hemophilia A mice with pre-existing factor VIII immunity.
    Doering CB; Gangadharan B; Dukart HZ; Spencer HT
    Mol Ther; 2007 Jun; 15(6):1093-9. PubMed ID: 17387335
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelet gene therapy by lentiviral gene delivery to hematopoietic stem cells restores hemostasis and induces humoral immune tolerance in FIX(null) mice.
    Chen Y; Schroeder JA; Kuether EL; Zhang G; Shi Q
    Mol Ther; 2014 Jan; 22(1):169-77. PubMed ID: 24042561
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sustained phenotypic correction of hemophilia a mice following oncoretroviral-mediated expression of a bioengineered human factor VIII gene in long-term hematopoietic repopulating cells.
    Moayeri M; Ramezani A; Morgan RA; Hawley TS; Hawley RG
    Mol Ther; 2004 Nov; 10(5):892-902. PubMed ID: 15509507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bone marrow stromal cells as targets for gene therapy of hemophilia A.
    Chuah MK; Brems H; Vanslembrouck V; Collen D; VandenDriessche T
    Hum Gene Ther; 1998 Feb; 9(3):353-65. PubMed ID: 9508053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correction of murine Bernard-Soulier syndrome by lentivirus-mediated gene therapy.
    Kanaji S; Kuether EL; Fahs SA; Schroeder JA; Ware J; Montgomery RR; Shi Q
    Mol Ther; 2012 Mar; 20(3):625-32. PubMed ID: 22044935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Directed engineering of a high-expression chimeric transgene as a strategy for gene therapy of hemophilia A.
    Doering CB; Denning G; Dooriss K; Gangadharan B; Johnston JM; Kerstann KW; McCarty DA; Spencer HT
    Mol Ther; 2009 Jul; 17(7):1145-54. PubMed ID: 19259064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of megakaryocytes to synthesize and store a releasable pool of human factor VIII.
    Wilcox DA; Shi Q; Nurden P; Haberichter SL; Rosenberg JB; Johnson BD; Nurden AT; White GC; Montgomery RR
    J Thromb Haemost; 2003 Dec; 1(12):2477-89. PubMed ID: 14675082
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo enrichment of genetically manipulated platelets for murine hemophilia B gene therapy.
    Chen Y; Schroeder JA; Gao C; Li J; Hu J; Shi Q
    J Cell Physiol; 2021 Jan; 236(1):354-365. PubMed ID: 32510630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.